A case report of neutrophilic fixed drug eruption

Authors

  • Waritta Dararattanaroj INSTITUTE OF DERMATOLOGY, BANGKOK
  • Prapawan Chawvavanich INSTITUTE OF DERMATOLOGY, BANGKOK
  • Poonnawis Sudtikoonaseth INSTITUTE OF DERMATOLOGY, BANGKOK

Keywords:

neutrophilic fixed drug eruption, fixed drug eruption, mefenamic acid

Abstract

Neutrophilic fixed drug eruption is a rare histopathological finding of fixed drug eruption (FDE). Whether it is a new entity or an early phase of FDE requires further investigation. We report a 34-year-old Thai female presented with multiple well-demarcated oval pruritic erythematous patches with dusky violaceous to brownish hue in the center on face, trunk and thigh. The rashes were aggravated by mefenamic acid ingestion, and improved by drug cessation. Histologic findings revealed large amount of pigmentary incontinence, also perivascular and interstitial infiltration with neutrophils and lymphohistocytes. To our knowledge, this is the first report of neutrophilic fixed drug reaction caused from mefenamic acid ingestion.

References

1. Korkij W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol 1984; 120: 520-4.

2. Patel TK, Thakkar SH, Sharma D. Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J. 2014; 5: S76-86.

3. Ozkaya E. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008; 6: 181-8.

4. Van Voorhees A, Stenn KS. Histological phases of Bactrim-induced fixed drug eruption. The report of one case. Am J Dermatopathol 1987; 9: 528-32.

5. Agnew KL, Oliver GF. Neutrophilic fixed drug eruption. Australas J Dermatol 2001;42: 200-2.

6. Ozkaya E, Büyükbabani N. Neutrophilic fixed drug eruption caused by naproxen: a real entity or a stage in the histopathologic evolution of the disease? J Am Acad Dermatol 2005; 53: 178-9.

7. Soares T, DiCaudo D, Warschaw K. Neutrophilic fixed drug eruption. J Am Acad Dermatol 2007; 56: AB49.

8. Waldman L, Reddy SB, Kassim A, Dettloff J, Reddy VB. Neutrophilic Fixed Drug Eruption. Am J Dermatopathol 2015; 37: 574-6.

9. Pak Y, Stollberg-Zagar K, Mayersohn M. A porcine model for fixed drug eruptions in humans: the case of antipyrine in the Yucatan micropig. J Appl Toxicol 2006; 26: 1-4.

10. Zaouak A, Ben Brahim E, Ben Tanfous A, et al. Mucosal fixed drug eruption due to mefenamic acid: Report of a case and a review. Therapie 2018; 73: 433-5.

11. Pérez-Pérez L, García-Gavín J, Allegue F, Zulaica A. Multifocal fixed drug eruption probably induced by mefenamic acid. Actas Dermosifiliogr 2013;104 :85-7.

12. Handisurya A, Moritz KB, Riedl E, Reinisch C, Stingl G, Wöhrl S. Fixed drug eruption caused by mefenamic acid: a case series and diagnostic algorithms. J Dtsch Dermatol Ges 2011; 9: 374-8.

13. Long CC, Finlay AY, Marks R. Fixed drug eruption to mefenamic acid: a report of three cases. Br J Dermatol 1992; 126: 409-11.

14. Mohamed KN. Extensive fixed eruption to mefenamic acid. Aust N Z J Med 1991; 21:290-1.

15. Sowden JM, Smith AG. Multifocal fixed drug eruption mimicking erythema multiforme. Clin Exp Dermatol 1990; 15: 387-8.

16. Watson A, Watt G. Fixed drug eruption to mefenamic acid. Australas J Dermatol 1986; 27:6-7.

17. Rallis E, Rigopoulos D, Anyfantakis V, et al. 'Dalmatian dog'-like skin eruption (two cases of multifocal fixed drug eruption induced by mefenamic acid). J Eur Acad Dermatol Venereol 2005; 19: 753-5.

18. Dar NR, Masood S, Mustafvi SA. Reticulated multifocal fixed drug eruption due to mefenamic acid-a new morphological pattern. J Coll Physicians Surg Pak 2005; 15: 562-3.

Downloads

Published

2018-12-21

How to Cite

Dararattanaroj, W., Chawvavanich, P., & Sudtikoonaseth, P. (2018). A case report of neutrophilic fixed drug eruption. Thai Journal of Dermatology, 34(4), 272–278. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/162664